Albert S. Khouri, M.D., a professor of ophthalmology at the Rutgers New Jersey Medical School, discusses teleophthalmology’s role in outreach efforts and improving ophthalmic care in the emergency room.
Telehealth’s chief attraction may be convenience, but Albert Khouri, M.D. says telehealth in ophthalmology — “teleophthalmology” — can help close the divisions of healthcare disparity and improve emergency room care.
Khouri, a professor of ophthalmology at Rutgers New Jersey Medical School, was one of the instructors of an educational session on innovations in teleophthalmology yesterday at the annual meeting of the American Academy of Ophthalmology in San Francisco.
In an interview with Managed Healthcare Executive, Khouri describes an outreach program that connects eye health screenings with soup kitchen, community centers and places of worship with ophthalmologists who review the data that is collected and make recommendations.
Khouri also discusses a pilot project at his medical school that involves an ophthalmology station and evaluating patients in the emergency room with optical coherence tomography. The images are then reviewed remotely by an ophthalmologist.
The other instructors for the teleophthalmology educational session were April Y Maa, M.D., Andrew G. Lee, M.D., Roomasa Channa, M.D., David J. Ramsey, M.D.,and Lama A. Al-Aswad, M.D., M.P.H. The senior instructor was Gary L. Legault, M.D.
High-Dose Eylea Shows Unique Properties in nAMD and DME | AAO 2024
October 22nd 2024A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks to as long as 20 weeks for neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME).
Read More
The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024
Published: October 21st 2024 | Updated: October 21st 2024Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy complications in patients. But this could be an early worsening of disease unrelated to treatment.
Read More